Specifically, the IL-6 cytokine is an essential player in the progression of cachexia in cancer as its levels correlate with the survival of advanced cancer patients [17], and it is a sensitive indicator of muscle mass loss in patients with colon and lung cancer [18,19,20]. Here, IL6 is linked to cancer.